Maternal hypothyroidism and future pediatric neurological morbidity of the offspring

Gil Gutvirtz1, Asnat Walfisch2, Tamar Wainstock3

  • 1Department of Obstetrics and Gynecology, Soroka University Medical Center, Ben-Gurion University of the Negev, 151 Izak Rager Ave., 84101, Beer-Sheva, Israel. Giltzik@gmail.com.

Insights

Maternal hypothyroidism during pregnancy is linked to increased long-term neurological issues in children. This study confirms an independent association between maternal thyroid conditions and pediatric neurological morbidity.

Area of Science:

  • Obstetrics and Gynecology
  • Pediatric Neurology
  • Endocrinology

Background:

  • Maternal hypothyroidism during pregnancy is a known risk factor for neurocognitive deficits in children.
  • Previous studies suggest a range of impairments, from developmental delays to reduced IQ scores.

Purpose of the Study:

  • To investigate the long-term neurological morbidity in children born to mothers with hypothyroidism during pregnancy.
  • To establish a potential independent association between maternal hypothyroidism and pediatric neurological health outcomes.

Main Methods:

  • A population-based cohort study analyzed over 200,000 deliveries spanning 20 years.
  • Neurological-related hospitalizations up to age 18 were evaluated using predefined ICD-9 codes.
  • Kaplan-Meier curves and Cox regression models controlled for multiple confounding factors.

Main Results:

  • 1.1% of deliveries (2403) were from mothers with known hypothyroidism.
  • Children of mothers with hypothyroidism showed a significantly higher cumulative incidence of neurological hospitalizations (p=0.007).
  • Maternal hypothyroidism was independently associated with pediatric neurological morbidity (adjusted HR=1.33, p=0.01) after controlling for confounders.

Conclusions:

  • Maternal hypothyroidism during pregnancy is an independent risk factor for long-term neurological morbidity in offspring.
  • These findings highlight the importance of managing maternal thyroid health for pediatric neurological outcomes.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
225
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
285
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
213
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
272
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
37.1K
Crossing Over01:34

Crossing Over

Unlike mitosis, meiosis aims for genetic diversity in its creation of haploid gametes. Dividing germ cells first begin this process in prophase I, where each chromosome—replicated in S phase—is now composed of two sister chromatids (identical copies) joined centrally.
The homologous pairs of sister chromosomes—one from the maternal and one from the paternal genome—then begin to align alongside each other lengthwise, matching corresponding DNA positions in a process...
171.7K